Fuelling innovation across disciplines with government grants, industry partnerships, and institutional seed money — empowering faculty and students to pursue impactful research.
ACU's research ecosystem is powered by a diversified funding model spanning government agencies, industry partners, clinical trials at AIMS, and dedicated internal seed grants that nurture early-stage investigations.
Ministry of Textiles, VGST, ICMR, and KSCST grants supporting 8 major research projects and student projects.
Pharmaceutical research and biotech partnerships with leading companies.
23 non-government funded clinical trials at AIMS across pharma, biotech, and vaccine research (2018-2026).
Internal grants across 6 faculties funding 27 innovative projects in 2025.
Prestigious grants from national and state agencies recognising ACU's research capabilities — totalling approximately ₹2.68 Crore from the Ministry of Textiles, VGST Karnataka, and ICMR across 8 major funded projects (2022-2026).
ICMR — Dr. Naveen Y P, Dr. Prashantha Kalappa, Dr. Amita K
Ministry of Textiles, Central Silk Board (2022)
Ministry of Textiles, Central Silk Board (2022)
VGST, Karnataka — Dr. Sudhanva M S, Dr. Girish Y R
VGST, Karnataka — Dr. P.S. Goudnavar, Dr. Raghavendra N N
VGST, Karnataka — Dr. Naveen Y P, Dr. Sudhanva M S
Royal Society of Chemistry — Dr. K. Prashantha
ICMR — Dr. Veena Dharmayat, Dr. Amita K
ICMR — Dr. Shreya Johri, Dr. Amita K
ICMR — Dr. Bhoomika, Dr. Mahendra, Dr. Amita K
VGST, Karnataka (2021)
VGST, Karnataka (2021)
Small grants supporting undergraduate research across engineering disciplines.
| Department | No. of Projects | Grant (₹ Lakhs) |
|---|---|---|
| Civil Engineering | Multiple | 0.04 – 0.07 each |
| Computer Science & Engineering | Multiple | 0.04 – 0.07 each |
| Electronics & Communication | Multiple | 0.04 – 0.07 each |
| Information Science & Engineering | Multiple | 0.04 – 0.07 each |
Indian Council of Medical Research (ICMR) — Multiple Short-Term Studentships awarded to ACU medical students annually for research training in clinical, biomedical and public health disciplines.
Collaborative research with pharmaceutical and biotech leaders, including vaccine, drug-delivery, and clinical-trial partnerships at AIMS.
Biological E Limited / IQVIA — Dr Ravi B N, Department of Medicine
Veeda Clinical Research Limited — Dr Vinay H R, Department of Psychiatry
Star Hi Herbs — Dr Ravi B N, Department of Medicine
Zuventus Healthcare Ltd. — Dr Jeevan Kumar J, Critical Care Unit
Biological E Limited — Dr Ravi B N, Department of Medicine
Unique Biotech — Dr Ravi K S, Department of ENT
Eversana — Dr Ravindra Pukale, Department of OBG
Biosphere Clinical Research Pvt Ltd — Dr Pooja H V, Department of Ophthalmology
Dabur Research & Development Centre — Dr. Pandareesh M D, Dr. Dinesha R
Himalaya Wellness — Dr Ravi B N, Department of Medicine
Cyrus Research India Private Limited — Dr Ravi B N, Department of Medicine
23 industry-sponsored clinical trial projects conducted at Adichunchanagiri Institute of Medical Sciences (AIMS), spanning vaccine research, pharmaceutical studies, and medical device trials from 2018 to 2026, with a combined value of approximately Rs 2.03 Crore.
| # | Sponsor | Study | Funding (₹) | Period |
|---|---|---|---|---|
| 1 | Unique Biotech | Probiotics on Exam Stress | 2,50,000 | 2018-19 |
| 2 | Unique Biotech | L. Reuteri on Infantile Colic | 10,00,000 | 2019-20 |
| 3 | Apex Laboratories | Sofinox Gel in Diabetic Wound Healing | 24,00,000 | 2019-22 |
| 4 | Lambda Therapeutic | COVID-19 Hyper-Immunoglobulin | 22,00,000 | 2020-21 |
| 5 | IQVIA | CORBEVAX Phase II/III | 36,00,000 | 2020-22 |
| 6 | Biosphere Clinical | Ropin Heavy Spinal Anaesthesia | 5,00,000 | 2020-22 |
| 7 | Alkem | Metformin + Sitagliptin + Pioglitazone | 65,000 | 2021-22 |
| 8 | Scitus Pharma | Absorbable Hemostat Powder | 19,00,000 | 2021-22 |
| 9 | Alkem | ENZ105 vs Ranibizumab | 57,000 | 2021-22 |
| 10 | Navitas Life Sciences | Anti-Rho(D) Immunoglobulin | 4,55,000 | 2021-22 |
| 11 | Veeda Clinical | Brimonidine + Timolol Bioequivalence | 9,00,000 | 2021-23 |
| 12 | Unique Biotech | S. Salivarius UBSS-01 Safety | 6,00,000 | 2022-23 |
| 13 | Biosphere Clinical | Atropine for Myopia | 3,80,000 | 2023-24 |
| 14 | Himalaya Wellness | HRPT-091514 in CKD | 2,00,000 | 2023-24 |
| 15 | Eversana | Livogen in Iron Deficiency Anemia | 6,00,000 | 2023-24 |
| 16 | Cyrus Research | Migraelief Device for Migraine | 2,00,000 | 2023-24 |
| 17 | Veeda Clinical | Paliperidone Palmitate in Schizophrenia | 21,00,000 | 2022-25 |
| 18 | Star Hi Herbs | Cissus for Weight Reduction | 14,00,000 | 2023-25 |
| # | Sponsor | Study | Funding (₹) | Period |
|---|---|---|---|---|
| 19 | Biological E | Hexavalent Vaccine Phase III | 10,84,000 | 2025-26 |
| 20 | Biological E | IPV Vaccine Phase III | 19,56,000 | 2025-26 |
| 21 | Apex Laboratories | Sofinox Gel Phase III | 9,18,000 | 2025-26 |
| 22 | Neuheit Research | Aviptadil in ARDS | 1,63,000 | 2025-26 |
Biological E — Scheduled 2026-27
ACU's dedicated seed money programme funds early-stage research across all constituent faculties, enabling faculty to develop proof-of-concept studies and attract external funding.
The 27 individually-funded ACU Seed Money projects for 2025 are currently being finalised by the Research & Innovation Council. Faculty-wise project titles, principal investigators and detailed budget allocations will be added here once the official sanction list is released.
A visual breakdown of research funding across government grants, industry partnerships, clinical trials at AIMS, and internal seed money.
ACU encourages all faculty members to apply for internal seed grants. Follow the streamlined process below to submit your research proposal.
Define your research problem, objectives, and expected outcomes aligned with ACU's research priorities.
Submit a detailed proposal with methodology, timeline, budget breakdown, and expected deliverables.
Proposals are reviewed by the Research Committee and approved by the Vice Chancellor's office.
Approved projects receive phased funding with milestone-based release of subsequent tranches.
Explore funding opportunities, apply for seed grants, or connect with our Research Cell for guidance on external funding.